YAP 和 TAZ 介导的肝星状细胞增殖有助于肝缺血再灌注损伤后的肝修复和再生。
Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
机构信息
Department of Surgery, University of Cincinnati, College of Medicine , Cincinnati, Ohio.
出版信息
Am J Physiol Gastrointest Liver Physiol. 2018 Apr 1;314(4):G471-G482. doi: 10.1152/ajpgi.00153.2017. Epub 2018 Jan 11.
Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are key regulators of cell proliferation and organ size; however, their physiological contribution after liver injury has not been fully understood. In this study, we sought to determine the role of YAP and TAZ during liver recovery after ischemia-reperfusion (I/R). A murine model of partial (70%) I/R was used to induce liver injury and study the reparative and regenerative response. After liver injury, there was marked activation and proliferation of hepatic stellate cells. The Hippo pathway components, large tumor suppressor 1 (LATS1) and its adapter protein, Mps one binder 1 (MOB1), were inactivated during liver repair, and YAP and TAZ were activated selectively in hepatic stellate cells. Concurrently, the expression of connective tissue growth factor and survivin, both of which are YAP and TAZ target genes, were upregulated. Hepatic stellate cell expansion and concomitant activation of YAP and TAZ occurred only in the injured liver and were not observed in the nonischemic liver. Treatment of mice with verteporfin, an inhibitor of YAP and TAZ, decreased hepatic stellate cell proliferation, survivin, and cardiac ankyrin repeat protein expression. These changes were associated with a significant decrease in hepatocyte proliferation. The data suggest that liver repair and regeneration after I/R injury are dependent on hepatic stellate cell proliferation, which is mediated by YAP and TAZ. NEW & NOTEWORTHY This study is the first to assess the proliferation of hepatic stellate cells (HSCs) after ischemia-reperfusion (I/R) injury and their role in the reparative and regenerative process. Here we show that the Hippo pathway is inactivated after I/R and that Yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ) activation is detected in HSC. HSC proliferation and expansion are prominent during liver recovery after I/R injury. Inhibition of YAP/TAZ activation with verteporfin reduces HSC proliferation and target gene expression and attenuates hepatocyte proliferation.
Yes 相关蛋白 (YAP) 和含 PDZ 结合基序的转录共激活因子 (TAZ) 是细胞增殖和器官大小的关键调节因子;然而,它们在肝损伤后的生理贡献尚未完全了解。在这项研究中,我们试图确定 YAP 和 TAZ 在肝缺血再灌注 (I/R) 后恢复期间的作用。使用部分 (70%) I/R 的小鼠模型诱导肝损伤并研究修复和再生反应。肝损伤后,肝星状细胞明显活化和增殖。Hippo 通路成分,大肿瘤抑制因子 1 (LATS1) 和其衔接蛋白,Mps 结合蛋白 1 (MOB1),在肝修复过程中失活,YAP 和 TAZ 选择性地在肝星状细胞中激活。同时,结缔组织生长因子和存活素的表达上调,它们都是 YAP 和 TAZ 的靶基因。肝星状细胞扩张以及 YAP 和 TAZ 的伴随激活仅发生在受损的肝脏中,而在非缺血的肝脏中未观察到。用维替泊芬 (verteporfin) 治疗小鼠,维替泊芬是 YAP 和 TAZ 的抑制剂,可减少肝星状细胞增殖、存活素和心脏锚蛋白重复蛋白的表达。这些变化与肝细胞增殖显著减少有关。数据表明,I/R 损伤后肝修复和再生依赖于肝星状细胞增殖,这是由 YAP 和 TAZ 介导的。本研究首次评估了缺血再灌注 (I/R) 损伤后肝星状细胞 (HSCs) 的增殖及其在修复和再生过程中的作用。在这里,我们表明 Hippo 通路在 I/R 后失活,并且在 HSC 中检测到 Yes 相关蛋白/转录共激活因子与 PDZ 结合基序 (YAP/TAZ) 激活。在 I/R 损伤后肝恢复期间,HSC 增殖和扩张明显。用维替泊芬抑制 YAP/TAZ 激活可减少 HSC 增殖和靶基因表达,并减弱肝细胞增殖。